Effect of Buprenorphine Weekly Depot (CAM2038) and Hydromorphone Blockade in Individuals With Opioid Use Disorder: A Randomized Clinical Trial

IMPORTANCE: Buprenorphine is an efficacious, widely used treatment for opioid use disorder (OUD). Daily oral transmucosal formulations can be associated with misuse, diversion, and nonadherence; these limitations may be obviated by a sustained release formulation. OBJECTIVE: To evaluate the ability...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:JAMA Psychiatry
Main Authors: Walsh, Sharon L., Comer, Sandra D., Lofwall, Michelle R., Vince, Bradley, Levy-Cooperman, Naama, Kelsh, Debra, Coe, Marion A., Jones, Jermaine D., Nuzzo, Paul A., Tiberg, Fredrik, Sheldon, Behshad, Kim, Sonnie
Formato: Artigo
Idioma:Inglês
Publicado em: American Medical Association 2017
Assuntos:
Original Investigation
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5710238/
https://ncbi.nlm.nih.gov/pubmed/28655025
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1001/jamapsychiatry.2017.1874
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados